Jerik Verula
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 1
- Genetics 6
- Genetic Associations and Epidemiology 6
- Journals
- JAMA (7 papers)Nature (4 papers)Nature Communications (1 paper)Human Genetics and Genomics Advances (1 paper)Institutional Repositories DataBase (IRDB) (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Jerik Verula
13 papers receiving 1.6k citations
Jerik Verula's Hit Papers
Peers
Comparison fields: 5 of 83
- Infectious Diseases 801
- Genetics 504
- Neurology 88
- Internal Medicine 18
- Immunology 103
Countries citing papers authored by Jerik Verula
This map shows the geographic impact of Jerik Verula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerik Verula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerik Verula more than expected).
Fields of papers citing papers by Jerik Verula
This network shows the impact of papers produced by Jerik Verula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerik Verula. The network helps show where Jerik Verula may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 3 | 2021 | 166 | |
| 4 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 5 | 2022 | 105 | |
| 6 | 2022 | 100 | |
| 7 | Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis Hit paper breakdown → | 2024 | 94 |
| 8 | 2023 | 60 | |
| 9 | 2023 | 46 | |
| 10 | 2023 | 34 | |
| 11 | 2025 | 13 | |
| 12 | 2024 | 8 | |
| 13 | 2024 | 6 | |
| 14 | 2021 | 0 |
About Jerik Verula
Jerik Verula is a scholar working on Infectious Diseases, Genetics, Nutrition and Dietetics, Pharmacology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 1.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Genetic Associations and Epidemiology (6 papers), Respiratory Support and Mechanisms (1 paper), Vitamin C and Antioxidants Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Infectious Diseases (801 citations), Genetics (504 citations), Neurology (88 citations), Internal Medicine (18 citations) and Immunology (103 citations). Jerik Verula has collaborated with scholars based in United Kingdom. Their work appears in journals such as JAMA, Nature, Nature Communications, Human Genetics and Genomics Advances and Institutional Repositories DataBase (IRDB).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.